August 22, 2026 — RNews

#hepatocellular carcinoma — Saturday, August 22, 2026 (1 items)

hot top new

← prev day next day →

10

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial. (linkinghub.elsevier.com)

Sun HC … Fan J The Lancet 2026-08-22

#hepatocellular carcinoma #clinical trial #immunotherapy #surgery #oncology